Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stenner-Liewen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinomaF Stenner-Liewen, V Grünwald, R Greil, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 17, 2006
[Molecular targeted therapy]F Stenner-Liewen, A Zippelius, B C Pestalozzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2000
Definition of tumor-associated antigens in hepatocellular carcinomaF Stenner-Liewen, G Luo, U Sahin, et al.
Leukemia|May 21, 2016
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysisD Juskevicius, T Lorber, J Gsponer, et al.
Bone Marrow Transplantation|December 7, 2010
Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trialR H Knols, E D de Bruin, D Uebelhart, et al.
Annals of Surgical Oncology|January 6, 2011
Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastasesPanagiotis Samaras, S Breitenstein, S R Haile, et al.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinomaF Stenner-Liewen, V Grünwald, R Greil, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 17, 2006
[Molecular targeted therapy]F Stenner-Liewen, A Zippelius, B C Pestalozzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2000
Definition of tumor-associated antigens in hepatocellular carcinomaF Stenner-Liewen, G Luo, U Sahin, et al.
Leukemia|May 21, 2016
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysisD Juskevicius, T Lorber, J Gsponer, et al.
Bone Marrow Transplantation|December 7, 2010
Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trialR H Knols, E D de Bruin, D Uebelhart, et al.
Annals of Surgical Oncology|January 6, 2011
Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastasesPanagiotis Samaras, S Breitenstein, S R Haile, et al.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Pageof 1